|
Çѱ¹ÈÀÌÀÚÁ¦¾à ÀÓ¿øÀλç(2019³â 1¿ù1ÀÏÀÚ, Á¤·Ä±âÁØ ºÎ¼ ³» À̸§ °¡³ª´Ù¼ø)
¡âÀü¹«
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ ¹× ÀÇÇкΠÃѰý (Innovative Medicines Business, Country Medical Director & Internal Medicine Medical Lead) °¼º½Ä Àü¹«
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ¿°Áõ ¹× ¸é¿ªÁúȯ »ç¾÷ºÎ ÃѰý (Innovative Medicines Business, Inflammation & Immunology Lead) ±èÈñ¿¬ Àü¹«
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ¹é½Å »ç¾÷ºÎ ÃѰý (Innovative Medicines Business, Vaccine Lead) ÀÓ¼Ò¸í Àü¹«
¡ãÀλçºÎ ÃѰý (HR BOS Lead) ÀÌÀº¹Ì Àü¹«
¡â»ó¹«
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, È£½ºÇÇÅ» »ç¾÷ºÎ ÃѰý (Innovative Medicines Business, Hospital Lead) ±èÈñÁ¤ »ó¹«
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, Èñ±ÍÁúȯ »ç¾÷ºÎ ÃѰý (Innovative Medicines Business, Rare Disease Lead) Á¶¿¬Áø »ó¹«
¡ãÀÓ»ó½ÃÇèºÎ (Global Site and Study Operations) ÃѰý ÇÑÀ±´ö »ó¹«
¡âÀÌ»ç
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ, ¿µ¾÷ÆÀ (Innovative Medicines Business, Internal Medicine, Sales) ±èâ½Ä ÀÌ»ç
¡ãÀçÁ¤ºÎ (Finance) ¹®ÈñÁ¤ ÀÌ»ç
¡ãÀçÁ¤ºÎ (Finance) ½ÅÇö±¹ ÀÌ»ç
¡ãÀ̽ºÅÂºí¸®½¬Æ® ¸Þµð½¼ »ç¾÷ºÎ¹®, ¿µ¾÷ÆÀ (Established Medicines Business, Sales) À̸íÁø ÀÌ»ç
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ, ¸¶ÄÉÆÃÆÀ (Innovative Medicines Business, Internal Medicine, Marketing Lead) ÀÌÁöÀº ÀÌ»ç
¡ãÀ̽ºÅÂºí¸®½¬Æ® ¸Þµð½¼ »ç¾÷ºÎ¹®, ´ë¿ÜÇù·ÂºÎ (Established Medicines Business, Corporate Affairs & Health and Value) À念ÁÖ ÀÌ»ç
¡ã±¸¸ÅºÎ (Global Procurement Lead) Á¤ÁöÈñ ÀÌ»ç
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ³»°úÁúȯ »ç¾÷ºÎ, ÀÇÇкΠ(Innovative Medicines Business, Internal Medicine, Medical) ÃÖÈñ¿¬ ÀÌ»ç
¡ãÀ̳뺣ÀÌÆ¼ºê ¸Þµð½¼ »ç¾÷ºÎ¹®, ´ë¿ÜÇù·ÂºÎ (Innovative Medicines Business, Corporate Affairs) Ç¥ÁöÇö ÀÌ»ç
|